Role of liver stiffness in prediction of adverse outcomes in heart failure
J Cardiol
.
2019 Feb;73(2):185-186.
doi: 10.1016/j.jjcc.2018.07.007.
Epub 2018 Aug 31.
Authors
Dhrubajyoti Bandyopadhyay
1
,
Kumar Ashish
2
,
Kartik Dhaduk
3
,
Upasana Banerjee
4
,
Samhati Mondal
5
,
Eyal Herzog
6
Affiliations
1
Mount Sinai St Luke's Roosevelt Hospital, New York, NY, USA. Electronic address: dhrubajyoti.bandyopadhyay@mountsinai.org.
2
Crozer-Chester Medical Center, Philadelphia, PA, USA.
3
Westchester Medical Center/New York Medical College, Valhalla, NY, USA.
4
Baylor College of Medicine, Houston, TX, USA.
5
Department of Cardiothoracic Anesthesia, Johns Hopkins University Hospital, Baltimore, MD, USA.
6
Echocardiography Laboratories, Mount Sinai St Luke's Roosevelt Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
PMID:
30177303
DOI:
10.1016/j.jjcc.2018.07.007
No abstract available
Keywords:
Fibroscan; Heart failure; Liver stiffness.
Publication types
Letter
Comment
MeSH terms
Biomarkers
Cardiomyopathy, Hypertrophic*
Elasticity Imaging Techniques*
Heart Failure*
Humans
Liver Cirrhosis
Prognosis
Tenascin
Substances
Biomarkers
Tenascin